Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Breast Cancer|Adenocarcinomas|Metastatic Solid Tumors Characterized by HER2/Neu Expression
Interventions: BIOLOGICAL: Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
Sponsor: National Cancer Institute (NCI)